Daclizumab Subcutaneous and Propulsid (Cisapride Suspension)
Determining the interaction of Daclizumab Subcutaneous and Propulsid (Cisapride Suspension) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclizumab
Brand name: Zinbryta, Zenapax
Synonyms: Daclizumab
Generic Name: cisapride
Brand name: Propulsid
Synonyms: Propulsid (Suspension), Propulsid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclizumab Subcutaneous-Propulsid (Cisapride Tablets)
- Daclizumab Subcutaneous-Propylhexedrine
- Daclizumab Subcutaneous-Propylthiouracil
- Daclizumab Subcutaneous-ProQuad
- Daclizumab Subcutaneous-Proquin XR
- Daclizumab Subcutaneous-Prorex
- Propulsid (Cisapride Suspension)-Dacogen
- Propulsid (Cisapride Suspension)-Dacomitinib
- Propulsid (Cisapride Suspension)-Dactinomycin
- Propulsid (Cisapride Suspension)-Dactinomycin Injection
- Propulsid (Cisapride Suspension)-Dactinomycin Intravenous
- Propulsid (Cisapride Suspension)-Daklinza